CARISMA Therapeutics Inc (CARM)
1.52
+0.24
(+18.75%)
USD |
NASDAQ |
Jun 28, 16:00
1.54
+0.02
(+1.32%)
Pre-Market: 20:00
CARISMA Therapeutics Total Assets (Quarterly): 73.80M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 73.80M |
| December 31, 2023 | 89.55M |
| September 30, 2023 | 106.78M |
| June 30, 2023 | 133.01M |
| Date | Value |
|---|---|
| March 31, 2023 | 156.13M |
| December 31, 2022 | 72.15M |
| June 30, 2022 | 97.36M |
| December 31, 2021 | 35.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
35.45M
Minimum
Dec 2021
156.13M
Maximum
Mar 2023
95.53M
Average
93.46M
Median
Total Assets (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 129.52M |
| Moderna Inc | 16.73B |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.90M |
| Shareholders Equity (Quarterly) | 10.90M |
| Current Ratio | 4.638 |
| Net Debt Paydown Yield | 7.15% |